Medical Oncology Assoc. Prof. Dr. Elif Şenocak Taşçı
✓ Medically verified profileAssoc. Prof. Dr. Elif Şenocak Taşçı
✓ Medically verified profile
Quick answer
Assoc. Prof. Dr. Elif Şenocak Taşçı is a Medical Oncology specialist at Acibadem Atakent Hospital in İstanbul with 7+ years of experience.
She treats metastatic melanoma, advanced gastric cancer, gastroesophageal junction cancer, esophageal adenocarcinoma, locally advanced rectal cancer, relapsed or refractory Hodgkin lymphoma, and triple-negative breast cancer, and handles immune checkpoint inhibitor therapy, nivolumab plus chemotherapy, total neoadjuvant therapy, neoadjuvant chemoradiation, adjuvant capecitabine therapy, perioperative FLOT chemotherapy, and BEGEV chemotherapy. She consults…
About Assoc. Prof. Dr. Elif Şenocak Taşçı
Assoc. Prof. Dr. Elif Şenocak Taşçı is a Medical Oncology specialist with 7 years of experience. Her listed areas of expertise include triple-negative breast cancer, metastatic melanoma, gastroesophageal junction cancer, relapsed or refractory Hodgkin lymphoma, immune checkpoint inhibitor therapy, total neoadjuvant therapy, adjuvant capecitabine therapy, and BEGEV chemotherapy.
Dr. Şenocak Taşçı graduated from Yeditepe University Faculty of Medicine in 2012. She completed Internal Medicine training at Duzce University Faculty of Medicine in 2017 and Medical Oncology training at Acıbadem Mehmet Ali Aydınlar University Faculty of Medicine in 2023. She was an Internal Medicine Specialist at Haydarpasa Numune Training and Research Hospital from 2019 to 2020 and a Medical Oncology Specialist at Kanuni Sultan Süleyman Training and Research Hospital from 2023 to 2025. She joined Acibadem Health Group in 2025 and practises at Acibadem Atakent Hospital in İstanbul, Türkiye.
The profile lists 10 publications dated between 2022 and 2025. Their subjects include osteoporosis risk and prognostic assessment in cancer patients, immune checkpoint inhibitors in metastatic melanoma, and treatment-related studies involving gastric, gastroesophageal junction, esophageal, rectal, breast, and Hodgkin lymphoma conditions.
Dr. Şenocak Taşçı speaks Turkish and English. Online consultation is available, allowing patients abroad to speak with the doctor before travelling.
Areas of Expertise
Conditions treated and procedures performed by this specialist.
Education
- 2023Acıbadem Mehmet Ali Aydınlar University Faculty of Medicine Medical Oncology
- 2017Duzce University Faculty of Medicine Internal Medicine
- 2012Yeditepe University Faculty of Medicine
Professional Experience
- 2025Acibadem Health Group
- 2023–2025Kanuni Sultan Süleyman Training and Research Hospital / Medical Oncology Specialist
- 2019–2020Haydarpasa Numune Training and Research Hospital / Internal Medicine Specialist
Selected Publications
- A multi-center case-control study on osteoporosis risk in cancer patients receiving chemotherapy. J Clin Oncol. 2025 ;43(16_suppl): 1203 3. Goktas Aydin S, Aydin A, Demirel BC, et al.
- Predicting osteoporosis in elderly cancer patients using the modified Glasgow prognostic index Cancer Control. 2025;32:10732748251337601. Ustuner M, Goktas Aydin S, Aydin A, et al
- Real world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: a Turkish oncology group retrospective study. Mol Clin Oncol. 2025;22(6):51. Ozgun A, Mustafayev FNA, Dogan I, et al
- Assessment of health literacy and HPV knowledge among university students: an observational study Medicine (Baltimore). 2024; 103(35). Senocak Tasci E, Bas D, Kayak S, et al.
- Real-world efficacy and safety of fırst-line nivolumab plus chemotherapy in patients with advanced gastric, gastroesophageal junction, and esophageal esophageal adenocarcinoma: a nationwide observational Turkish Oncology Group (TOG) study. Cancers (Basel). 2024; 16(12):2251. Kutlu Y, Shute DA, Yilmaz F, et al.
- Total neoadjuvant therapy versus neoadjuvant chemoradiation for locally advanced rectal cancer: a multi-institutional real-world study. Cancers (Basel). 2024; 16( 18):3213. Senocak Tasci E, Mutlu AU, Saylik O, et al
- BEGEV is an effective therapy for heavily pretreated and platinum-resistant relapsed/refractory Hodgkin’s lymphoma patients: a single-center real-life experience. Indian J Hematol Blood Transfus. 2024 Uzay A, Tasci ES, Gundogdu Y, et al.
- Efficacy of adjuvant capecitabine in residual triple-negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study. Expert Opin Pharmacother. 2024:1-8. Tasci ES, Kutlu Y, Ölmez ÖF, et al
- Turkish adaptation of QEQ-SH22 quality of sexual life assessment scale in cancer patients – validity and reliability study Sisli Etfal Hastan Tip Bul. 2024;58(4):468-476. Eriş SB, Celayir OM, Tasci ES, et al.
- Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group). Turkish J Med Sci. 2022;52(4): 1022-1032. Erol C, Sakin A, Basoglu T, et al.
Frequently Asked Questions
What is Dr. Elif Şenocak Taşçı's specialty?
Which hospital does Dr. Elif Şenocak Taşçı practise at?
What languages can I use when consulting Dr. Elif Şenocak Taşçı?
How can I book an appointment with Dr. Elif Şenocak Taşçı?
Is an online video consultation available with Dr. Elif Şenocak Taşçı?
Can international patients arrange treatment with Dr. Elif Şenocak Taşçı?
How do I get a second opinion involving Dr. Elif Şenocak Taşçı?
A dedicated team, from first message to follow-up
Our international patient office coordinates your appointment, travel and treatment at JCI-accredited Acıbadem hospitals — and stays with you in your own language, every step of the way.
Schedule your appointment with Assoc. Prof. Dr. Elif Şenocak Taşçı
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
Hospitals
Medical Units
What patients say about Assoc. Prof. Dr. Elif Şenocak Taşçı
★★★★★From 2,400+ verified patient reviews“Years of worry ended once I came here for my sedation during my procedure. Dr. Eskitaşçıoğlu made a stressful situation feel completely manageable. I felt looked after at every turn.”
“After struggling for a long time, I finally found the right care for my immunotherapy here. Assoc. Prof. Dr. Taşçı explained every step clearly and never rushed me. I would happily travel here again for any treatment.”